New Developments in Psychopharmacology — MRCPsych Paper A MCQs & EMIs
New Developments in Psychopharmacology for MRCPsych Paper A: Recently approved and pipeline drugs — KarXT, cariprazine, lumateperone, esketamine,…
What New Developments in Psychopharmacology covers
Recently approved and pipeline drugs — KarXT, cariprazine, lumateperone, esketamine, zuranolone, dextromethorphan-bupropion, lecanemab, GLP-1 agonists, TAAR1 agonists, orexin antagonists, and novel mechanisms.
Question practice is available to signed-in members. Sign in or register for a 3-day free trial, or see pricing.